GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Margin of Safety % (DCF FCF Based)

LAVA Therapeutics NV (LAVA Therapeutics NV) Margin of Safety % (DCF FCF Based) : N/A (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

LAVA Therapeutics NV's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


Competitive Comparison of LAVA Therapeutics NV's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, LAVA Therapeutics NV's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LAVA Therapeutics NV's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Margin of Safety % (DCF FCF Based) falls into.



LAVA Therapeutics NV Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry
Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines

From GuruFocus

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer

By Stock market mentor Stock market mentor 02-06-2023

LAVA Announces Annual Meeting of Shareholders

By GlobeNewswire GlobeNewswire 05-30-2023

LAVA Therapeutics Announces Appointment of New Directors to the Board

By Stock market mentor Stock market mentor 01-06-2023